DK1077935T3 - Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer - Google Patents
Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorerInfo
- Publication number
- DK1077935T3 DK1077935T3 DK99919771T DK99919771T DK1077935T3 DK 1077935 T3 DK1077935 T3 DK 1077935T3 DK 99919771 T DK99919771 T DK 99919771T DK 99919771 T DK99919771 T DK 99919771T DK 1077935 T3 DK1077935 T3 DK 1077935T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylethylamines
- phenylsulfonamide
- alkyl
- dopamine receptors
- nhcoch3
- Prior art date
Links
- 102000015554 Dopamine receptor Human genes 0.000 title 1
- 108050004812 Dopamine receptor Proteins 0.000 title 1
- GNLBKOISUOPBOL-UHFFFAOYSA-N benzenesulfonamide;2-phenylethanamine Chemical class NCCC1=CC=CC=C1.NS(=O)(=O)C1=CC=CC=C1 GNLBKOISUOPBOL-UHFFFAOYSA-N 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 102000004073 Dopamine D3 Receptors Human genes 0.000 abstract 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8549398P | 1998-05-14 | 1998-05-14 | |
| PCT/US1999/007023 WO1999058499A1 (en) | 1998-05-14 | 1999-05-07 | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1077935T3 true DK1077935T3 (da) | 2004-02-16 |
Family
ID=22191975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99919771T DK1077935T3 (da) | 1998-05-14 | 1999-05-07 | Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6103766A (da) |
| EP (1) | EP1077935B1 (da) |
| JP (1) | JP2002514623A (da) |
| KR (1) | KR20010043546A (da) |
| CN (1) | CN1152857C (da) |
| AT (1) | ATE253045T1 (da) |
| AU (1) | AU752543B2 (da) |
| BR (1) | BR9910405A (da) |
| CA (1) | CA2327345A1 (da) |
| DE (1) | DE69912419T2 (da) |
| DK (1) | DK1077935T3 (da) |
| EA (1) | EA002918B1 (da) |
| ES (1) | ES2211078T3 (da) |
| HU (1) | HUP0101746A3 (da) |
| IL (1) | IL139263A0 (da) |
| NO (1) | NO20005732D0 (da) |
| NZ (1) | NZ508152A (da) |
| PL (1) | PL343891A1 (da) |
| PT (1) | PT1077935E (da) |
| SK (1) | SK16242000A3 (da) |
| TR (1) | TR200003325T2 (da) |
| TW (1) | TW450954B (da) |
| WO (1) | WO1999058499A1 (da) |
| ZA (1) | ZA200005921B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0971878B1 (en) * | 1997-02-27 | 2008-03-26 | Takeda Pharmaceutical Company Limited | Amine compounds, their production and use as amyloid-beta production inhibitors |
| US6849635B2 (en) * | 2001-05-07 | 2005-02-01 | Smithkline Beecham Corporation | Sulfonamides |
| WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| EP2311802A1 (en) | 2004-10-14 | 2011-04-20 | Abbott GmbH & Co. KG | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| EP2371814A1 (en) | 2004-10-14 | 2011-10-05 | Abbott GmbH & Co. KG | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| CA2583333C (en) | 2004-10-14 | 2013-05-14 | Abbott Gmbh & Co. Kg | Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| ES2360254T3 (es) * | 2006-04-14 | 2011-06-02 | ABBOTT GMBH & CO. KG | Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3. |
| AR060462A1 (es) | 2006-04-14 | 2008-06-18 | Abbott Gmbh & Co Kg | Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3 |
| WO2007118899A1 (en) | 2006-04-19 | 2007-10-25 | Abbott Gmbh & Co. Kg | Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor |
| JP2009534355A (ja) | 2006-04-19 | 2009-09-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | セロトニン５ｈｔ６受容体の調節に応答する障害を治療するために好適な複素環化合物 |
| WO2008026046A1 (en) * | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574741A (en) * | 1969-04-14 | 1971-04-13 | Mead Johnson & Co | Sulfonamidophenalkylamines |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| GB9402197D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Compounds |
| CN1088062C (zh) * | 1994-11-23 | 2002-07-24 | 纽罗根公司 | 某些4－氨基甲基－2－取代的咪唑衍生物2－氨基甲基－4－取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体 |
| AU2897497A (en) * | 1996-05-11 | 1997-12-05 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| DE69734215T2 (de) * | 1996-07-22 | 2006-06-29 | Novo Nordisk A/S | Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften |
| JPH1180156A (ja) * | 1997-09-04 | 1999-03-26 | Hokuriku Seiyaku Co Ltd | １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体 |
-
1999
- 1999-04-26 TW TW088106644A patent/TW450954B/zh not_active IP Right Cessation
- 1999-05-07 EA EA200001184A patent/EA002918B1/ru not_active IP Right Cessation
- 1999-05-07 IL IL13926399A patent/IL139263A0/xx not_active IP Right Cessation
- 1999-05-07 EP EP99919771A patent/EP1077935B1/en not_active Expired - Lifetime
- 1999-05-07 PL PL99343891A patent/PL343891A1/xx unknown
- 1999-05-07 AT AT99919771T patent/ATE253045T1/de not_active IP Right Cessation
- 1999-05-07 NZ NZ508152A patent/NZ508152A/xx unknown
- 1999-05-07 HU HU0101746A patent/HUP0101746A3/hu unknown
- 1999-05-07 CN CNB998052175A patent/CN1152857C/zh not_active Expired - Fee Related
- 1999-05-07 DE DE69912419T patent/DE69912419T2/de not_active Expired - Fee Related
- 1999-05-07 CA CA002327345A patent/CA2327345A1/en not_active Abandoned
- 1999-05-07 DK DK99919771T patent/DK1077935T3/da active
- 1999-05-07 JP JP2000548303A patent/JP2002514623A/ja not_active Withdrawn
- 1999-05-07 PT PT99919771T patent/PT1077935E/pt unknown
- 1999-05-07 SK SK1624-2000A patent/SK16242000A3/sk unknown
- 1999-05-07 AU AU37418/99A patent/AU752543B2/en not_active Ceased
- 1999-05-07 TR TR2000/03325T patent/TR200003325T2/xx unknown
- 1999-05-07 US US09/306,748 patent/US6103766A/en not_active Expired - Fee Related
- 1999-05-07 KR KR1020007012661A patent/KR20010043546A/ko not_active Abandoned
- 1999-05-07 WO PCT/US1999/007023 patent/WO1999058499A1/en not_active Ceased
- 1999-05-07 ES ES99919771T patent/ES2211078T3/es not_active Expired - Lifetime
- 1999-05-07 BR BR9910405-9A patent/BR9910405A/pt not_active Application Discontinuation
-
2000
- 2000-10-23 ZA ZA200005921A patent/ZA200005921B/en unknown
- 2000-11-13 NO NO20005732A patent/NO20005732D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL139263A0 (en) | 2001-11-25 |
| NZ508152A (en) | 2003-03-28 |
| KR20010043546A (ko) | 2001-05-25 |
| HUP0101746A3 (en) | 2002-10-28 |
| SK16242000A3 (sk) | 2001-06-11 |
| EA002918B1 (ru) | 2002-10-31 |
| CN1152857C (zh) | 2004-06-09 |
| WO1999058499A1 (en) | 1999-11-18 |
| PT1077935E (pt) | 2004-03-31 |
| EA200001184A1 (ru) | 2001-04-23 |
| ATE253045T1 (de) | 2003-11-15 |
| EP1077935B1 (en) | 2003-10-29 |
| HUP0101746A2 (hu) | 2002-03-28 |
| JP2002514623A (ja) | 2002-05-21 |
| CN1297431A (zh) | 2001-05-30 |
| ES2211078T3 (es) | 2004-07-01 |
| NO20005732L (no) | 2000-11-13 |
| US6103766A (en) | 2000-08-15 |
| ZA200005921B (en) | 2001-11-14 |
| EP1077935A1 (en) | 2001-02-28 |
| DE69912419T2 (de) | 2004-07-22 |
| AU3741899A (en) | 1999-11-29 |
| TW450954B (en) | 2001-08-21 |
| TR200003325T2 (tr) | 2001-04-20 |
| PL343891A1 (en) | 2001-09-10 |
| CA2327345A1 (en) | 1999-11-18 |
| NO20005732D0 (no) | 2000-11-13 |
| AU752543B2 (en) | 2002-09-19 |
| DE69912419D1 (de) | 2003-12-04 |
| HK1036049A1 (en) | 2001-12-21 |
| BR9910405A (pt) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005732D0 (no) | Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer | |
| DK0923542T3 (da) | Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander | |
| AP2002002481A0 (en) | Biaryl ether derivatives useful as monoamine reuptake inhibitors. | |
| ES2031513T3 (es) | Quinazolindionas y piridopirimidinadionas. | |
| YU56301A (sh) | Inhibitori resorpcije monoamina za tretiranje poremećaja cns | |
| NO973532L (no) | 2-aminoindaner som selektive dopamin D3-ligander | |
| PE20020911A1 (es) | Derivados de indol como agonistas de 5ht2 | |
| PE20031011A1 (es) | Derivados de dihidrobenzodiazepin-2-ona-iii | |
| NO20032253L (no) | Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer | |
| HRP20030003B1 (en) | N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives | |
| DE60014339D1 (de) | Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren | |
| DE60003899D1 (de) | Aryl-annellierte disubstituierte pyridine : nk3 rezeptor-liganden | |
| PE20021003A1 (es) | Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri) | |
| ATE157977T1 (de) | Chinoxalinderivate als eaa antagonisten | |
| PE20060632A1 (es) | Derivados de arilsulfonilestilbeno como antagonistas de los receptores 5-ht2a | |
| ES2182509T3 (es) | Derivados de n-ariloxietilamina para el tratamiento de la depresion. | |
| PE20030540A1 (es) | Derivados de amidas de acido antranilico como inhibidores del receptor de tirosina quinasa de vegf | |
| EA199900043A1 (ru) | ПРОИЗВОДНЫЕ ПИРИДИЛКАРБАМОИЛИНДОЛИНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ 5-НТ2с-РЕЦЕПТОРОВ | |
| PE20040788A1 (es) | Derivados de indol con afinidad al receptor de androgeno | |
| ES2062495T3 (es) | Nuevos compuestos broncoespasmoliticos y procedimiento para su preparacion. | |
| HUP0103358A2 (hu) | N-Szubsztituált aza-bicikloheptán-származékok, előállításuk és alkalmazásuk | |
| HUP9800889A1 (hu) | Új naftil-piperazin-származékok | |
| AR009786A1 (es) | Pirrolcarboxamidas fusionadas, una nueva clase de ligandos receptores cerebrales gaba |